ArticleDrug design, development and therapy2014

Immunomodulatory effects of 17-O-acetylacuminolide in RAW264.7 cells and HUVECs: involvement of MAPK and NF-κB pathways.

Mouna Achoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.